Active Ingredient: CIPROFLOXACIN HYDROCHLORIDE; HYDROCORTISONE
Proprietary Name: CIPRO HC
Dosage Form; Route of Administration: SUSPENSION/DROPS; OTIC
Strength: EQ 0.2% BASE;1%
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N020805
Product Number: 001
Approval Date: Feb 10, 1998
Applicant Holder Full Name: SANDOZ INC
Marketing Status:
Prescription
Patent and Exclusivity Information
